John F. Runkel Jr - Aug 19, 2022 Form 4 Insider Report for SYNOPSYS INC (SNPS)

Role
GC & Corporate Secretary
Signature
By: POA pursuant Christina Escalante-Dutra For: John Frederick Runkel, Jr.
Stock symbol
SNPS
Transactions as of
Aug 19, 2022
Transactions value $
-$800,452
Form type
4
Date filed
8/22/2022, 01:21 PM
Previous filing
Jun 8, 2022
Next filing
Sep 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNPS Common Stock Options Exercise $133K +569 +2.52% $234.17 23.2K Aug 19, 2022 Direct
transaction SNPS Common Stock Sale -$208K -569 -2.45% $365.49 22.6K Aug 19, 2022 Direct F1
transaction SNPS Common Stock Options Exercise $214K +1.57K +6.95% $135.88 24.2K Aug 19, 2022 Direct
transaction SNPS Common Stock Sale -$575K -1.57K -6.5% $365.49 22.6K Aug 19, 2022 Direct F1
transaction SNPS Common Stock Options Exercise $119K +1.32K +5.85% $89.76 23.9K Aug 19, 2022 Direct
transaction SNPS Common Stock Sale -$484K -1.32K -5.52% $365.49 22.6K Aug 19, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNPS Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.32K -33.33% $0.00 2.65K Aug 19, 2022 Common Stock 1.32K $89.76 Direct F2, F3
transaction SNPS Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.57K -14.29% $0.00 9.43K Aug 19, 2022 Common Stock 1.57K $135.88 Direct F2, F3
transaction SNPS Non-Qualified Stock Option (right to buy) Options Exercise $0 -569 -9.08% $0.00 5.7K Aug 19, 2022 Common Stock 569 $234.17 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $361.89 to $368.85. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.